Multicomponent Reactions of 1,3-Cyclohexanediones and Formaldehyde in Glycerol
1148, 1123, 1067, 962, 758, 700, 658, 531 cmÀ1; HR-MS:
m/z=256.1427, calcd. for C17H20O2 [M+]: 256.1463.
1654, 1627, 1495, 1448, 1388, 1309, 1291, 1268, 1231, 1164,
1119, 1189, 1070, 1032, 1005, 965, 935, 854, 764, 701,
658 cmÀ1; HR-MS: m/z=270.1648, calcd. for C18H22O2 [M+]:
270.1620.
2,3,4,6,7,8-Hexahydro-2-(4-chlorophenyl)-7,7-dimethyl-
5H-1-benzopyran-5-one (3b): White solid, mp 132–1338C;
1H NMR (CDCl3): d=1.09 (s, 3H), 1.11 (s, 3H), 1.84 (dtd,
Ja =4.8 Hz, Jb =8.4 Hz, Jc =10.4 Hz, 1H), 2.15 (double quint,
Ja =2.8 Hz, Jb =13.6 Hz, 1H), 2.26 (s, 1H), 2.28 (s, 1H),
2.20–2.30 (m, 1H), 2.34 (s, 2H), 2.40–2.49 (m, 1H), 4.94 (dd,
Ja =2.4 Hz, Jb =6.4 Hz, 1H), 7.7 (d, J=8.4 Hz,2H), 7.35
(d, J=8.4 Hz, 2H); 13C NMR: d=17.7, 27.7, 29.0, 29.1, 32.1,
42.4, 50.6, 78.3, 110.3, 127.3, 127.4, 128.8, 133.9, 138.8, 169.5,
197.9. IR: n=2944, 2870, 1649, 1626, 1491, 1394, 1345, 1286,
1234, 1213, 1164, 1144, 1124, 1070, 1010, 991, 965, 900, 867,
843, 818, 617, 539 cmÀ1; HR-MS: m/z=290.1097, calcd. for
C17H19ClO2 [M+]: 290.1074.
2,3,4,6,7,8-Hexahydro-2-(4-fluorophenyl)-2,7,7-trimethyl-
5H-1-benzopyran-5-one (3g): Colourless liquid; 1H NMR
(CDCl3): d=1.56 (s, 3H), 1.85–1.94 (m, 2H), 1.94–2.04 (m,
2H), 2.17–2.23 (m, 1H), 2.25–2.32 (m, 1H), 2.32–2.38 (m,
2H), 2.48–2.55 (m, 2H), 7.02 (dt, Ja =2.4 Hz, Jb =6.8 Hz,
2H), 7.23–7.28 (m, 2H); 13C NMR: d=15.7, 21.0, 28.9, 29.0,
32.5, 36.7, 80.2, 111.4, 115.2, 115.4, 126.0, 126.1, 140.4, 140.4,
160.6, 163.1, 170.0, 198.0; IR: n=2957, 2932, 2870, 1654,
1628, 1511, 1452, 1389, 1309, 1292, 1266, 1230, 1163, 1119,
1077, 837, 651 cmÀ1; HR-MS: m/z=288.1560, calcd. for
C18H21FO2 [M+]: 288.1526.
2,3,4,6,7,8-Hexahydro-2-(4-methylphenyl)-7,7-dimethyl-
5H-1-benzopyran-5-one (3c): White solid, mp 76–778C;
1H NMR (CDCl3): d=1.08 (s, 3H), 1.10 (s, 3H), 1.89 (dtd,
Ja =5.6 Hz, Jb =10.8 Hz, Jc =16.0 Hz, 1H), 2.15 (double
quint, Ja =2.8 Hz, Jb =13.6 Hz, 1H), 2.25 (s, 1H), 2.28 (s,
1H), 2.20–2.30 (m, 1H), 2.33 (s, 2H), 2.36 (s, 3H), 2.41–2.49
(m, 1H), 4.93 (dd, Ja =2.4 Hz, Jb =10.4 Hz, 1H), 7.18 (d, J=
8.0 Hz, 2), 7.23 (d, J=8.0 Hz, 2H); 13C NMR: d=17.8, 21.2,
27.7, 28.9, 29.2, 32.1, 42.5, 50.6, 79.0, 110.2, 125.9, 129.3,
137.3, 138.0, 169.9, 189.5, 198.0; IR: n=2957, 2928, 2870,
1656, 1627, 1517, 1393, 1368, 1306, 1287, 1233, 1210, 1164,
1123, 1071, 1054, 962, 815, 772, 632 cmÀ1; HR-MS: m/z=
270.1656, calcd. for C18H22O2 [M+]: 270.1620.
2,3,4,6,7,8-Hexahydro-2-(4-methoxylphenyl)-7,7-dimethyl-
5H-1-benzopyran-5-one (3d): White solid, mp 122–1248C;
1H NMR (CDCl3): d=1.08 (s, 3H), 1.09 (s, 3H), 1.89 (dtd,
Ja =5.6 Hz, Jb =10.8 Hz, Jc =14.0 Hz, 1H), 2.13 (double
quint, Ja =2.8 Hz, Jb =14.0 Hz, 1H), 2.25 (s, 1H), 2.28 (s,
1H), 2.20–2.30 (m, 1H), 2.32 (s, 2H), 2.43–2.52 (m, 1H),
3.81 (s, 3H), 4.90 (dd, Ja =2.4 Hz, Jb =10.4 Hz, 1H), 6.91 (d,
J=8.8 Hz, 2H), 7.27 (d, J=8.8 Hz, 2H); 13C NMR: d=18.0,
27.7, 28.8, 29.2, 32.1, 42.5, 50.6, 55.3, 78.9, 110.2, 114.0, 127.4,
132.3, 159.5, 170.0, 198.0; IR: n=2950, 2914, 1624, 1516,
1468, 1444, 1396, 1360, 1307, 1291, 1249, 1231, 1209, 1177,
1164, 1126, 1069, 1054, 1028, 838, 812, 642, 628, 568,
530 cmÀ1; HR-MS: m/z=286.1583, calcd. for C18H22O3 [M+]:
286.1569.
2,3,4,6,7,8-Hexahydro-2-(4-tert-butylphenyl)-7,7-dimethyl-
5H-1-benzopyran-5-one (3e): White solid, mp 64–658C;
1H NMR (CDCl3): d=1.08 (d, J=4.4 Hz, 6H), 1.33 (s, 9H),
1.89 (dtd, Ja =6.0 Hz, Jb =10.4 Hz, Jc =13.6 Hz, 1H), 2.16
(double quint, Ja =2.8 Hz, Jb =14.0 Hz, 1H), 2.20–2.30 (m,
3H), 2.33 (s, 2H), 2.42–2.50 (m, 1H), 4.94 (dd, Ja =2.4 Hz,
Jb =10.4 Hz, 1H), 7.27 (d, J=8.8 Hz, 2H), 7.41 (d, J=
6.8 Hz, 2H); 13C NMR: d=17.8, 27.7, 28.8, 29.2, 31.3, 32.1,
34.6, 42.5, 50.6, 79.0, 110.3, 125.5, 125.7, 137.2, 151.2, 169.9,
198.0; IR: n=2959, 2870, 1657, 1628, 1515, 1466, 1392, 1367,
1286, 1233, 1210, 1164, 1123, 1071, 1054, 1016, 962, 835, 702,
624, 572 cmÀ1; HR-MS: m/z=312.2123, calcd. for C21H28O2
[M+]: 312.2089.
2,3,4,6,7,8-Hexahydro-2-phenyl-2,7,7-trimethyl-5H-1-ben-
zopyran-5-one (3f): Colourless liquid; 1H NMR (CDCl3):
d=1.07 (s, 3H), 1.09 (s, 3H), 1.57 (s, 3H), 1.80–1.95 (m,
2H), 2.22 (s, 2H), 2.23–2.32 (m, 2H), 2.41 (d, J=1.2 Hz,
2H), 7.21–7.29 (m, 3H), 7.29–7.37 (m, 2H); 13C NMR: d=
15.6, 28.4, 28.5, 29.3, 32.3, 32.5, 42.7, 50.6, 80.8, 110.1, 124.3,
127.2, 128.5, 144.6, 168.6, 197.8; IR: n=2956, 2932, 2870,
2,3,4,6,7,8-Hexahydro-2-phenyl-5H-1-benzopyran-5-one
(3h): Colourless liquid; H NMR (CDCl3): d=1.83–1.92 (m,
1
2H), 1.93–2.05 (m, 2H), 2.12–2.20 (m, 1H), 2.22–2.33 (m,
1H), 2.37–2.52 (m, 4H), 4.94 (dd, Ja =2.4 Hz, Jb =10.4 Hz,
1H), 7.31–7.41 (m, 5H); 13C NMR: d=18.2, 20.9, 28.7, 29.2,
36.7, 79.1, 111.7, 125.9, 128.2, 128.6, 140.3, 171.5, 198.3; IR:
n=2944, 2893, 1650, 1622, 1497, 1453, 1394, 1294, 1248,
1231, 1214, 1181, 1131, 1075, 1033, 1005, 984, 920, 862, 759,
701, 661, 588, 531 cmÀ1; HR-MS: m/z=228.1129, calcd. for
C15H16O2 [M+]: 228.1150.
2,3,4,6,7,8-Hexahydro-2-(4-chlorophenyl)-5H-1-benzopyr-
1
an-5-one (3i): White solid, mp 76–788C; H NMR (CDCl3):
d=1.78–1.90 (m, 2H), 1.93–2.06 (m, 2H), 2.14 (double
quint, Ja =3.2 Hz, Jb =14.0 Hz, 1H), 2.21–2.33 (m, 1H),
2.37–2.51 (m, 4H), 4.91 (dd, Ja =2.0 Hz, Jb =10.4 Hz, 1H),
7.28 (d, J=8.8 Hz, 2H), 7.35 (d, J=6.8 Hz, 2H); 13C NMR:
d=18.2, 20.9, 28.7, 29.2, 36.7, 79.1, 111.7, 125.9, 128.2, 128.6,
140.3, 171.5, 198.3; IR: n=2936, 1653, 1620, 1492, 1391,
1293, 1247, 1230, 1213, 1179, 1128, 1090, 1075, 1033, 922,
829, 605 cmÀ1
;
HR-MS: m/z=262.0739, calcd. for
C15H15ClO2 [M+]: 262.0761.
2,3,4,6,7,8-Hexahydro-2-(4-methylphenyl)-5H-1-benzopyr-
1
an-5-one (3j): White solid, mp 70–728C; H NMR (CDCl3):
d=1.85–1.95 (m, 1H), 1.96–2.02 (m, 2H), 2.13 (double
quint, Ja =2.4 Hz, Jb =10.4 Hz, 1H), 2.22–2.32 (m, 1H), 2.36
(s, 3H), 2.37–2.42 (m, 2H), 2.42–2.50 (m, 3H), 4.90 (dd, Ja =
2.0 Hz, Jb =10.4 Hz, 1H), 7.19 (d, J=8.0 Hz, 2H), 7.23 (d,
J=8.0 Hz, 2H); 13C NMR: d=18.2, 20.9, 21.1, 28.7, 29.0,
36.7, 79.1, 111.6, 126.0, 129.3, 137.3, 138.0, 171.6, 198.2; IR:
n=2946, 2930, 1642, 1615, 1516, 1452, 1427, 1398, 1368,
1294, 1250, 1235, 1185, 1130, 1077, 1034, 1004, 816, 622,
553 cmÀ1; HR-MS: m/z=242.1339, calcd. for C16H18O2 [M+]:
242.1307.
2,3,4,6,7,8-Hexahydro-2-(4-methoxylphenyl)-5H-1-benzo-
pyran-5-one (3k): Yellow solid, mp 102–1048C; 1H NMR:
d=1.85–1.92 (m, 1H), 1.93–2.02 (m, 2H), 2.08–2.17 (m,
1H), 2.20–2.31 (m, 1H), 2.34–2.52 (m, 5H), 3.80 (s, 3H),
4.87 (dd, Ja =2.0 Hz, Jb =10.4 Hz, 1H), 6.90 (d, J=8.4 Hz,
2H), 7.27 (d, J=8.8 Hz, 2H); 13C NMR: d=18.3, 20.9, 28.7,
28.9, 36.7, 55.3, 78.9, 111.5, 114.0, 127.4, 132.3, 159.6, 171.6,
198.2; IR: n=2947, 2916, 2834, 1651, 1626, 1515, 1390, 1290,
1251, 1180, 1131, 1075, 1031, 1001, 985, 837, 807, 616,
570 cmÀ1; HR-MS: m/z=258.1228, calcd. for C16H18O3 [M+]:
258.1256.
2,3,4,6,7,8-Hexahydro-2-methyl-2-phenyl-5H-1-benzopyr-
1
an-5-one (3l): Colourless liquid; H NMR (CDCl3): d=1.57
(s, 3H), 1.83–1.95 (m, 2H), 1.99 (quint, J=6.4 Hz, 2H),
Adv. Synth. Catal. 2010, 352, 519 – 530
ꢁ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
527